StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) shareholders

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.15−0.14 (-5.90%)

Close on Nov 17, 2026Market cap $9.63MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
4.8%
0M of 4M shares
Institutional holders
8
5 new, 3 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
6 buys · 1 sales
Net bought $172.80K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Armistice Capital, LLC
Joint filing with Steven Boyd (9.99%)
194,1329.99%13G (passive)Dec 31, 2025
Steven Boyd
Joint filing with Armistice Capital, LLC (9.99%)
142,7289.99%13G (passive)Jun 30, 2026
Waqas Khatri
Joint filing with Ayrton Capital LLC (9.99%), Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (9.99%)
107,7229.99%13G (passive)Jun 30, 2026
Mitchell P. Kopin
Joint filing with Daniel B. Asher (9.99%), Intracoastal Capital LLC (9.99%)
09.99%13G (passive)Jun 3, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of BJDXValueChange% of portfolio
Armistice Capital, LLC131,0002.93%$157.20KNew0.00%
Heights Capital Management, Inc35,4000.79%$42.48KNew0.01%
Boothbay Fund Management, LLC27,1300.61%$32.56KNew0.00%
Bank Of America Corp /De/10,3370.23%$12.40KNew0.00%
Vanguard Fiduciary Trust Co10,2250.23%$12.27KNew0.00%
Tower Research Capital LLC (TRC)1,9070.04%$2.29K+1780.00%
L1 Global Manager Pty Ltd1200.00%$144–0.00%
Caitong International Asset Management Co., Ltd10.00%$1−20.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202680M4.8%5 / 11 / 30M0M
Q1 202660M1.3%6 / 00 / 10M0M
Q4 202510M0.0%1 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

2 funds held BJDX in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of BJDXValue% of fundAs of
Fidelity Extended Market Index Fund25,1550.56%$53.83K0.00%May 31, 2026
Fidelity Series Total Market Index Fund1830.00%$3920.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Indranil DeyPresident and CEO, Director40,6490.91%Aug 18, 2026
Svetlana DeyDirector12,6280.28%Aug 18, 2026
Douglas Clark WurthDirector1,121,49125.10%Aug 18, 2026
Fred S. ZeidmanDirector12,5000.28%Aug 18, 2026
Donald R. ChaseDirector12,5250.28%Aug 18, 2026
Bofa Securities, Inc.10% owner80.00%Jul 22, 2026
Of America Na Bank10% owner––Jul 22, 2026
Of America Corp /De/ Bank10% owner80.00%Jul 22, 2026
Financial Lp Hrt10% owner92,0552.06%Jul 13, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Indranil Dey
President and CEO, Director
Aug 17, 2026Award+28,000––40,522
Financial Lp Hrt
10% owner
Jul 10, 2026Sale−34,938$1.40$48.91K92,055
Financial Lp Hrt
10% owner
Jul 9, 2026Buy+64,047$1.51$96.71K126,993
Indranil Dey
President and CEO, Director
Mar 14, 2026Buy+12,500$2.00$25.00K12,522
Douglas Clark Wurth
Director
Mar 14, 2026Buy+12,500$2.00$25.00K12,608
Fred S. Zeidman
Director
Mar 14, 2026Buy+12,500$2.00$25.00K12,500
Donald R. Chase
Director
Mar 14, 2026Buy+12,500$2.00$25.00K12,525
Svetlana Dey
Director
Mar 14, 2026Buy+12,500$2.00$25.00K12,501
Svetlana Dey
Director
Dec 13, 2023Buy+500$3.07$1.54K1,500
Indranil Dey
President and CEO, Director, 10% owner
Dec 13, 2023Buy+500$3.27$1.64K28,526
Indranil Dey
President and CEO, Director
Mar 28, 2023Buy+2,000$0.44$880660,538
Indranil Dey
President and CEO, Director
Mar 28, 2023Award+2,000$0.44$880660,538
Indranil Dey
President and CEO, Director
Mar 27, 2023Buy+8,000$0.44$3.52K558,538
Indranil Dey
President and CEO, Director
Mar 27, 2023Award+8,000$0.44$3.52K558,538
Svetlana Dey
Director
Mar 24, 2023Buy+10,000$0.44$4.40K47,500
Svetlana Dey
Director
Mar 24, 2023Award+10,000$0.44$4.40K47,500
Gary G. Gemignani
Director
Feb 1, 2023Award+27,500$0.44$12.10K27,500
Svetlana Dey
Director
Feb 1, 2023Award+27,500$0.44$12.10K37,500
Indranil Dey
President and CEO, Director
Feb 1, 2023Tax withholding−55,612$0.44$24.47K550,538
Indranil Dey
President and CEO, Director
Feb 1, 2023Award+159,090$0.44$70.00K606,150
Douglas Clark Wurth
Director
Feb 1, 2023Award+27,500$0.44$12.10K2,313,849
Fred S. Zeidman
Director
Feb 1, 2023Award+27,500$0.44$12.10K27,500
Kenneth R. Fisher
Chief Financial Officer
Feb 1, 2023Tax withholding−39,316$0.44$17.30K113,184
Kenneth R. Fisher
Chief Financial Officer
Feb 1, 2023Award+112,500$0.44$49.50K152,500
Donald R. Chase
Director
Feb 1, 2023Award+27,500$0.44$12.10K792,852
Kenneth R. Fisher
Chief Financial Officer
Aug 26, 2022Buy+20,000$1.03$20.60K40,000
Kenneth R. Fisher
Chief Financial Officer
Apr 25, 2022Buy+20,000$0.99$19.80K20,000
Gordon Winston Kinder
Chief Financial Officer
Mar 17, 2022Buy+2,500$1.16$2.90K18,500
Svetlana Dey
Director, 10% owner
Mar 17, 2022Buy+10,000$1.18$11.80K10,000
Douglas Clark Wurth
Director, 10% owner
Mar 17, 2022Buy+40,000$1.18$47.20K2,286,349
Douglas Clark Wurth
Director, 10% owner
Mar 16, 2022Buy+60,000$1.09$65.40K2,246,349
Gordon Winston Kinder
Chief Financial Officer
Mar 16, 2022Buy+5,000$1.02$5.10K16,000
Gordon Winston Kinder
Chief Financial Officer
Mar 15, 2022Buy+500$0.91$45511,000
Gordon Winston Kinder
Chief Financial Officer
Mar 14, 2022Buy+10,500$0.95$9.98K10,500

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
2.45%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-46.1%
From 0M shares
Short volume, 20 days
40.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Bluejay Diagnostics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 189,599 shares on Sep 9, 2026 over the last 90 days.

See a number that looks wrong?